Ras Oncogene Expression in Plasma Cell Dyscrasias
Author Information
Author(s): M. Danova, A. Riccardi, G. Ucci, R. Luoni, M. Giordano, G. Mazzini
Primary Institution: Universita di Pavia
Hypothesis
Is Ha-ras oncogene expression involved in the malignant transformation of plasma cells in multiple myeloma compared to monoclonal gammopathies of undetermined significance?
Conclusion
The study found that p21 expression is significantly higher in multiple myeloma patients compared to those with normal bone marrow or monoclonal gammopathies of undetermined significance.
Supporting Evidence
- All normal and MGUS bone marrow had diploid DNA content.
- 72.4% of multiple myeloma patients had diploid DNA content.
- p21 expression was significantly higher in multiple myeloma patients compared to normal and MGUS patients.
Takeaway
This study looked at how a specific protein related to cancer is more present in patients with a serious blood disease called multiple myeloma compared to those with a less serious condition.
Methodology
Bivariate flow cytometry was used to measure nuclear DNA content and p21 protein expression in bone marrow cells from patients.
Limitations
The study was limited by the small sample size and the specific patient population.
Participant Demographics
The study included 57 patients with plasma cell dyscrasia (28 with MGUS and 29 with MM) and 5 solid tumor patients.
Statistical Information
P-Value
<0.005
Statistical Significance
p<0.005
Want to read the original?
Access the complete publication on the publisher's website